Worst of Reverse Convertible

Symbol: MLURCH
ISIN: CH1273041611
Issuer:
Raiffeisen
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 96.29
Diff. absolute / % -0.05 -0.05%

Determined prices

Last Price 96.29 Volume 10,000
Time 16:51:23 Date 15/07/2024

More Product Information

Core Data

Name Worst of Reverse Convertible
ISIN CH1273041611
Valor 127304161
Symbol MLURCH
Quotation in percent Yes
Coupon p.a. 9.30%
Coupon Premium 4.84%
Coupon Yield 4.46%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency US Dollar
First Trading Date 20/06/2023
Date of maturity 20/06/2025
Last trading day 12/06/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded No
Pricing Dirty
Issuer Raiffeisen

Key data

Ask Price (basis for calculation) 97.0500
Maximum yield 12.65%
Maximum yield p.a. 13.62%
Sideways yield 12.65%
Sideways yield p.a. 13.62%

market maker quality Date: 15/07/2024

Average Spread 0.83%
Last Best Bid Price 95.53 %
Last Best Ask Price 96.33 %
Last Best Bid Volume 250,000
Last Best Ask Volume 190,000
Average Buy Volume 250,000
Average Sell Volume 213,445
Average Buy Value 239,937 USD
Average Sell Value 206,571 USD
Spreads Availability Ratio 100.00%
Quote Availability 100.00%

Underlyings

Name Pfizer Inc. Johnson & Johnson Merck & Co. Inc.
ISIN US7170811035 US4781601046 US58933Y1055
Price 26.91 EUR 138.15 EUR 116.30 EUR
Date 16/07/24 18:41 16/07/24 18:41 16/07/24 18:40
Cap 38.97 USD 160.01 USD 110.71 USD
Distance to Cap -9.64 -9.26 18.01
Distance to Cap in % -32.87% -6.14% 13.99%
Is Cap Level reached No No No
Barrier 19.49 USD 80.01 USD 55.36 USD
Distance to Barrier 9.84 70.74 73.36
Distance to Barrier in % 33.55% 46.93% 56.99%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.